Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-079019

Chief Executive Officer gave up 120,900 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SETH SANDESH Chief Executive Officer 2025-08-18 Shares withheld for taxes −120,900 $1.71 $206,739 184,481 D: show line 1 in the form
Loading xslF345X05/ownership.xml…